Phosphorylation of GSK3α/β correlates with activation of AKT and is prognostic for poor overall survival in acute myeloid leukemia patients
Open Access
- 1 December 2015
- journal article
- Published by Elsevier in BBA Clinical
- Vol. 4, 59-68
Abstract
No abstract availableKeywords
Funding Information
- Leukemia Lymphoma Society
- National Institutes of Health (CA-55164)
This publication has 39 references indexed in Scilit:
- The E-box Binding Factors Max/Mnt, MITF, and USF1 Act Coordinately with FoxO to Regulate Expression of Proapoptotic and Cell Cycle Control Genes by Phosphatidylinositol 3-Kinase/Akt/Glycogen Synthase Kinase 3 SignalingJournal of Biological Chemistry, 2011
- Low expression of PP2A regulatory subunit B55α is associated with T308 phosphorylation of AKT and shorter complete remission duration in acute myeloid leukemia patientsLeukemia, 2011
- O-Linked β-N-acetylglucosamine (O-GlcNAc) Regulates Stress-induced Heat Shock Protein Expression in a GSK-3β-dependent MannerJournal of Biological Chemistry, 2010
- Role for PKC in Fenretinide-Mediated Apoptosis in Lymphoid Leukemia CellsJournal of Signal Transduction, 2010
- GSK-3 Promotes Conditional Association of CREB and Its Coactivators with MEIS1 to Facilitate HOX-Mediated Transcription and OncogenesisCancer Cell, 2010
- Exploiting cellular pathways to develop new treatment strategies for AMLCancer Treatment Reviews, 2010
- Highly Phosphorylated FOXO3A Is an Adverse Prognostic Factor in Acute Myeloid LeukemiaClinical Cancer Research, 2010
- Glycogen synthase kinase 3: more than a namesakeBritish Journal of Pharmacology, 2009
- Systematic Discovery of In Vivo Phosphorylation NetworksCell, 2007
- S6K1 Regulates GSK3 under Conditions of mTOR-Dependent Feedback Inhibition of AktMolecular Cell, 2006